欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0470/001
药品名称Intratect
活性成分
    • human normal immunoglobulin 50.0 mg/ml
剂型Solution for infusion
上市许可持有人Biotest Pharma GmbH Postfach 10 20 40 D- 63266 Dreieich Germany
参考成员国 - 产品名称Germany (DE)
Intratect To CMS: Procedere requires finalisation of IA/27, started on 26.11.14
互认成员国 - 产品名称
    • Cyprus (CY)
      INTRATECT SOL FOR INFUSION
    • Slovenia (SI)
    • United Kingdom (Northern Ireland) (XI)
    • Greece (GR)
    • Poland (PL)
    • Hungary (HU)
      INTRATECT 50 g/l oldatos infúzió
    • Italy (IT)
    • Austria (AT)
      Intratect 50 g/l Infusionslösung
    • Ireland (IE)
    • France (FR)
    • Netherlands (NL)
    • Belgium (BE)
    • Finland (FI)
    • Portugal (PT)
    • Spain (ES)
    • Denmark (DK)
    • Malta (MT)
      Intratect
    • Romania (RO)
      Intratect 50 g/l, solutie perfuzabila
    • Czechia (CZ)
      Intratect
    • Bulgaria (BG)
    • Sweden (SE)
    • Croatia (HR)
    • Norway (NO)
许可日期2005/09/26
最近更新日期2024/04/05
药物ATC编码
    • J06BA02 immunoglobulins, normal human, for intravascular adm.
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier [Article 8.3(i)]
  • TypeLevel4:Biological: Blood Product
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase